Operating Expenses Summary of IntegraGen SA

IntegraGen SA's latest annual operating expenses in 2023 was 5.35 Million EUR , up 70.88% from previous year.
IntegraGen SA's latest quarterly operating expenses in 2024 Q2 was - EUR , down 0.0% from previous quarter.
IntegraGen SA reported a annual operating expenses of 103.46 Thousand EUR in annual operating expenses 2022, up 41.25% from previous year.
IntegraGen SA reported a annual operating expenses of 73.24 Thousand EUR in annual operating expenses 2021, down -11.62% from previous year.
IntegraGen SA reported a quarterly operating expenses of 64.99 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.
IntegraGen SA reported a quarterly operating expenses of 176.78 Thousand EUR for 2023 FY, up 70.88% from previous quarter.

Annual Operating Expenses Chart of IntegraGen SA (2023 - 2008)

Historical Annual Operating Expenses of IntegraGen SA (2023 - 2008)

Year	Operating Expenses	Operating Expenses Growth
2023	5.35 Million EUR	70.88%
2022	103.46 Thousand EUR	41.25%
2021	73.24 Thousand EUR	-11.62%
2020	82.87 Thousand EUR	-98.67%
2019	6.21 Million EUR	66.52%
2018	3.73 Million EUR	47.59%
2017	2.52 Million EUR	-26.06%
2016	3.42 Million EUR	14.28%
2015	2.99 Million EUR	8.17%
2014	2.76 Million EUR	-1.95%
2013	2.82 Million EUR	12.39%
2012	2.51 Million EUR	7.67%
2011	2.33 Million EUR	-43.2%
2010	4.1 Million EUR	113.6%
2009	1.92 Million EUR	52.5%
2008	1.26 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	- EUR	0.0%
2023 Q2	64.99 Thousand EUR	0.0%
2023 FY	176.78 Thousand EUR	70.88%
2023 Q4	2.42 Million EUR	0.0%
2022 Q4	4104.00 EUR	0.0%
2022 FY	103.46 Thousand EUR	41.25%
2022 Q2	99.35 Thousand EUR	0.0%
2021 Q2	2.53 Million EUR	0.0%
2021 FY	73.24 Thousand EUR	-11.62%
2021 Q4	8.83 Million EUR	0.0%
2020 Q2	211.81 Thousand EUR	0.0%
2020 FY	82.87 Thousand EUR	-98.67%
2020 Q4	-128.92 Thousand EUR	0.0%
2019 Q2	2.17 Million EUR	0.0%
2019 FY	6.21 Million EUR	66.52%
2019 Q4	174.42 Thousand EUR	0.0%
2018 Q2	1.81 Million EUR	0.0%
2018 Q4	1.91 Million EUR	0.0%
2018 FY	3.73 Million EUR	47.59%
2017 Q2	1.14 Million EUR	0.0%
2017 FY	2.52 Million EUR	-26.06%
2017 Q4	1.38 Million EUR	0.0%
2016 Q4	1.98 Million EUR	0.0%
2016 Q2	1.74 Million EUR	0.0%
2016 FY	3.42 Million EUR	14.28%
2015 FY	2.99 Million EUR	8.17%
2015 Q4	1.72 Million EUR	0.0%
2015 Q2	1.26 Million EUR	0.0%
2014 Q4	1.29 Million EUR	0.0%
2014 FY	2.76 Million EUR	-1.95%
2014 Q2	1.47 Million EUR	0.0%
2013 Q2	1.4 Million EUR	0.0%
2013 Q4	1.41 Million EUR	0.0%
2013 FY	2.82 Million EUR	12.39%
2012 Q4	56.89 Thousand EUR	26.55%
2012 Q3	44.95 Thousand EUR	0.0%
2012 FY	2.51 Million EUR	7.67%
2012 Q1	44.95 Thousand EUR	0.0%
2012 Q2	44.95 Thousand EUR	0.0%
2011 Q3	53.62 Thousand EUR	0.0%
2011 Q1	53.62 Thousand EUR	0.0%
2011 Q2	53.62 Thousand EUR	0.0%
2011 Q4	44.95 Thousand EUR	-16.16%
2011 FY	2.33 Million EUR	-43.2%
2010 Q4	53.62 Thousand EUR	-14.73%
2010 Q3	62.88 Thousand EUR	0.0%
2010 Q1	62.88 Thousand EUR	0.0%
2010 Q2	62.88 Thousand EUR	0.0%
2010 FY	4.1 Million EUR	113.6%
2009 FY	1.92 Million EUR	52.5%
2009 Q1	77.83 Thousand EUR	0.0%
2009 Q2	77.83 Thousand EUR	0.0%
2009 Q3	77.83 Thousand EUR	0.0%
2009 Q4	62.88 Thousand EUR	-19.21%
2008 Q1	37.72 Thousand EUR	0.0%
2008 Q2	37.72 Thousand EUR	0.0%
2008 Q3	37.72 Thousand EUR	0.0%
2008 FY	1.26 Million EUR	0.0%
2008 Q4	77.83 Thousand EUR	106.35%
2007 Q4	37.72 Thousand EUR	0.0%

Peer Operating Expenses Comparison of IntegraGen SA

Name	Operating Expenses	Operating Expenses Difference
ABIONYX Pharma SA	4.17 Million EUR	-28.142%
ABIVAX Société Anonyme	127.37 Million EUR	95.798%
Adocia SA	15.62 Million EUR	65.753%
Aelis Farma SA	18.81 Million EUR	71.558%
Biophytis S.A.	14.33 Million EUR	62.656%
Advicenne S.A.	8.21 Million EUR	34.845%
genOway Société anonyme	16.73 Million EUR	68.022%
Medesis Pharma S.A.	1.56 Million EUR	-242.107%
Neovacs S.A.	10.34 Million EUR	48.253%
NFL Biosciences SA	4.37 Million EUR	-22.361%
Plant Advanced Technologies SA	2.76 Million EUR	-93.591%
Quantum Genomics Société Anonyme	1.71 Million EUR	-211.561%
Sensorion SA	27.05 Million EUR	80.215%
Theranexus Société Anonyme	3 Million EUR	-78.121%
TME Pharma N.V.	5.49 Million EUR	2.629%
Valbiotis SA	9.86 Million EUR	45.764%
TheraVet SA	1.64 Million EUR	-225.516%
Valerio Therapeutics Société anonyme	20.32 Million EUR	73.659%
argenx SE	1.34 Billion EUR	99.601%
BioSenic S.A.	7.58 Million EUR	29.414%
Celyad Oncology SA	8.49 Million EUR	36.955%
DBV Technologies S.A.	89.4 Million EUR	94.013%
Galapagos NV	327.98 Million EUR	98.368%
Genfit S.A.	54.8 Million EUR	90.233%
GeNeuro SA	14.35 Million EUR	62.719%
Hyloris Pharmaceuticals SA	17.98 Million EUR	70.242%
Innate Pharma S.A.	64.57 Million EUR	91.711%
Inventiva S.A.	120.18 Million EUR	95.546%
MaaT Pharma SA	21.59 Million EUR	75.218%
MedinCell S.A.	32.92 Million EUR	83.742%
Nanobiotix S.A.	58.92 Million EUR	90.917%
Onward Medical N.V.	20.64 Million EUR	74.074%
Oryzon Genomics S.A.	18.49 Million EUR	71.063%
OSE Immunotherapeutics SA	23.58 Million EUR	77.309%
Oxurion NV	12.21 Million EUR	56.177%
Pharming Group N.V.	204.24 Million EUR	97.379%
Poxel S.A.	28.76 Million EUR	81.392%
GenSight Biologics S.A.	32.66 Million EUR	83.611%
Transgene SA	31.23 Million EUR	82.862%
Financière de Tubize SA	114.38 Thousand EUR	-4579.217%
UCB SA	2.94 Billion EUR	99.818%
Valneva SE	134.92 Million EUR	96.033%
Vivoryon Therapeutics N.V.	24.69 Million EUR	78.323%

Global Stocks Search

IntegraGen SA (ALINT.PA)

Operating Expenses Summary of IntegraGen SA

Annual Operating Expenses Chart of IntegraGen SA (2023 - 2008)

Historical Annual Operating Expenses of IntegraGen SA (2023 - 2008)

Peer Operating Expenses Comparison of IntegraGen SA